Light Reflection on Human Skin in Whole-Body Photobiomodulation Therapy

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-30
SponsorUniversidade Federal de Sao Carlos

About this trial

Photobiomodulation therapy (PBMT) is based on exposing biological tissues to low-intensity light, with effects depending on the light-tissue interaction. When irradiated without skin contact, part of the incident light is reflected and lost. In this context, the amount of reflected light in PBMT applied without skin contact, as well as the influence of skin phototype, has not yet been established. Objective: To quantify the reflection of light from PBMT on the skin of men and women aged 18 to 30 years, considering skin phototypes. Methodology: Participants will be divided into three groups based on skin phototype (Group 1: phototypes I and II; Group 2: phototypes III and IV; Group 3: phototypes V and VI) and sex. They will be subjected to whole-body PBMT with red light (660 nm; 31.85±3.85 mW; 45.50±5.07 mW/cm²) and infrared light (850 nm; 25.29±2.99 mW; 36.13±4.27 mW/cm²) at 20 cm from the light-emitting source, with measurement of light reflection in the regions of the brachial biceps, abdomen, lumbar, anterior and posterior thigh, and calf using a power and energy analyzer (powermeter PM100D and sensor S130C, 0.7 cm²). Data will be analyzed for normality and groups were compared with a significance level of 5%

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

male and female

age between 18 and 30 years

body mass index (BMI) between 18.5 and 29.9 kg/m2.

Disqualifiers

tattoo in the light reflection assessment areas

history of skin cancer

skin lesions such as open wounds in the mid-thigh, abdomen, biceps brachii, back and calf

patients with cognitive difficulty reporting thermal sensation

Trial design

Design model

Single group

Treatments tested in this trial

  • Whole-body Photobiomodulation Therapy

    Device

    Whole-body Photobiomodulation Therapy applied for approximately 10 minutes, being 5 minutes with the red wavelength and 5 minutes with the infrared wavelength.

Treatment groups

72 Participants
are divided into 1 treatment group
Group A: Photobiomodulation Reflection GroupExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Light Reflection

Light reflection will be measured in mW with a PowerMeter Device in the angles of 30º, 60º and 90º considering the participant in front of the whole-body photobiomodulation therapy device.

Time frame
Acute measurement. The measurement will be performed just during the light therapy irradiation, on the day of the procedure.

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.